Foghorn Therapeutics CEO Adrian Gottschalk's 2021 pay jumps 64% to $4.3M
Foghorn Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Foghorn Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, four executives at Foghorn Therapeutics received on average a compensation package of $2.5M, a 52% increase compared to previous year.
Average pay of disclosed executives at Foghorn Therapeutics
Adrian Gottschalk, Chief Executive Officer, received $4.3M in total, which increased by 64% compared to 2020. 78% of Gottschalk's compensation, or $3.4M, was in option awards. Gottschalk also received $405K in non-equity incentive plan and $540K in salary.
Allan Reine, Chief Financial Officer, received a compensation package of $2M. 67% of the compensation package, or $1.3M, was in option awards.
Carl Decicco, Chief Scientific Officer, earned $1.8M in 2021, a 49% increase compared to previous year.
Samuel Agresta, Chief Medical Officer, received $1.8M in 2021, which increases by 72% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 29, 2022.